In one aspect, the present disclosure provides a topical composition comprising a therapeutically effective amount of 5 О± reductase inhibitors, such as dutasteride or finasteride or pharmaceutically acceptable salts, esters, or derivatives thereof, and appropriate topical pharmaceutically acceptable excipients or carriers <a href=https://sviagrass.monster>can i take viagra with lisinopril</a>
